Claims
- 1. A method for detection of fungal DNA in clinical material comprising:a) isolating predominantly intact fungal cells from whole blood by disintegrating blood cells and isolating intact fungal cells; b) isolating fungal DNA from the intact fungal cells by disintegrating the intact fungal cells and isolating the fungal DNA; and c) amplifying at least one segment of the fungal DNA to be detected by polymerase chain reaction, wherein at least one of the nucleotide sequences SEQ ID-No: 1 or SEQ ID-No: 2 are used as a primer.
- 2. The method of claim 1, further comprising detecting amplification products.
- 3. The method of claim 2, wherein detecting amplification products comprises gel electrophoresis and staining the gel.
- 4. The method of claim 3, wherein said gel electrophoresis comprises an agarose gel and wherein ethidium bromide is used to stain said gel.
- 5. The method of claim 1, wherein the polymerase chain reaction is carried out with a cycle as follows:denaturing for 0.3-1 min at 90-96° C. hybridizing for 0.5-1.5 min at 58-64° C., and extending for 1.5-2.5 min at 63-75° C.
- 6. The method of claim 5, wherein denaturing is for 0.5 min at 94° C., wherein hybridizing is for 1 min at 62° C., and wherein extending is for 2 min at 72° C.
- 7. The method of claim 5, further comprising an initial denaturation step of 5-9 min at 90-96° C. before the start of the cycle.
- 8. The method of claim 7, wherein the initial denaturation step is for 3 min at 94° C.
- 9. The method of claim 1, wherein said at least one segment of fungal DNA amplified in step c) comprises a segment of a fungal gene for 18ssu-rRNA.
- 10. The method of claim 9, wherein SEQ ID-No: 1 is used as a primer for the polymerase chain reaction.
- 11. The method of claim 9, wherein SEQ ID-No: 2 is used as a primer for the polymerase chain reaction.
- 12. The method of claim 1, wherein isolating predominantly intact fungal cells from whole blood by disintegrating blood cells and isolating intact fungal cells, further comprises:forming a blood cell lysate by disintegrating erythrocytes by osmotic hemolysis and disintegrating leukocytes by enzymatic digestion; and centrifuging the resultant blood cell lysate to isolate the intact fungal cells from blood cell lysate.
- 13. The method of claim 12, wherein forming a blood cell lysate is carried out in a solution with a final concentration of 200 μg/ml of proteinase K, 10 mM Tris pH 7.6, 10 mM EDTA pH 8.0, 50 mM NaCl and 0.2% SDS.
- 14. The method of claim 13, wherein said solution is incubated for 100-140 min at 60-70° C.
- 15. The method of claim 13, wherein said solution is incubated for 120 min at 65° C.
- 16. The method of claim 12, wherein disintegrating erythrocytes by osmotic hemolysis comprises incubation in a hypotonic solution and a detergent at a final concentration of 10 mM Tris pH 7.6, 5 mM MgCl2 and 10 mM NaCl.
- 17. The method of claim 1, wherein isolating fungal DNA from the intact fungal cells by disintegrating the intact fungal cells and isolating the fungal DNA, comprises alkaline lysis and enzymatic treatment of the intact fungal cells.
- 18. The method of claim 1, wherein isolating fungal DNA from the intact fungal cells by disintegrating the intact fungal cells and isolating the fungal DNA, comprises:incubating the fungal cells for 5-15 min at 90-95° C. in a solution with 50 mM NaOH; neutralizing with 1 M Tris-HCl pH 7.0; treating with Zymolyase enzyme for 50-70 min at 30-40° C.; and denaturing protein by incubating with Tris/EDTA for 10-30 min at 60-70° C.
- 19. The method of claim 18, wherein incubating the fungal cells is for 10 min at 95° C., wherein treating with Zymolyase is for 60 min at 37° C., and wherein incubating with Tris/EDTA is for 20 min at 65° C.
- 20. The method of claim 1, wherein isolating fungal DNA from the intact fungal cells by disintegrating the intact fungal cells and isolating the fungal DNA, comprisesprecipitating protein with 5M potassium acetate; and precipitating DNA in ice-cold isopropanol.
- 21. The method of claim 1, further comprising:d) determining whether the nucleotide sequence of said at least one segment of fungal DNA is characteristic of a particular fungal strain and/or species, wherein said at least one segment of fungal DNA is hybridized with DNA probes specific for the particular fungal strain and/or species, said DNA probes being selected from the group consisting of SEQ ID-No: 3, SEQ ID-No: 4; SEQ ID-No: 5, SEQ ID-No-6, SEQ ID-No: 7 and SEQ ID-No: 8, and wherein a successful hybridization leads to identification of the fungal strain and/or species.
- 22. The method of claim 21, wherein the probes are labeled with dioxygenin and hybrids are detected for testing of successful hybridization.
- 23. The method according to claim 22, wherein detection of hybrids is by Southern-Blot analysis.
- 24. The method according to claim 21, wherein the DNA probes are used in the following sequential order SEQ ID-No: 3, SEQ ID-No: 8, SEQ ID-No: 6, SEQ ID-No: 7, SEQ ID-No: 4, and SEQ ID-No: 5, and wherein the hybridization is tested respectively.
- 25. A method for detection of fungal DNA in clinical material comprising:a) isolating predominantly intact fungal cells from whole blood by disintegrating blood cells by osmotic hemolysis and enzymatic digestion, and isolating intact fungal cells; b) isolating fungal DNA from the intact fungal cells by disintegrating the intact fungal cells by alkaline lysis and enzymatic treatment and isolating the fungal DNA; c) amplifying at least one segment of the fungal DNA to be detected by polymerase chain reaction; d) determining whether the nucleotide sequence of said at least one segment of fungal DNA is characteristic of a particular fungal strain and/or species, wherein said at least one segment of fungal DNA is hybridized with DNA probes specific for the particular fungal strain and/or species, said DNA probes being selected from the group consisting of SEQ ID-No: 3, SEQ ID-No: 4; SEQ ID-No: 5, SEQ ID-No-6, SEQ ID-No: 7 and SEQ ID-No: 8, and wherein a successful hybridization leads to identification of the fungal strain and/or species.
- 26. The method of claim 25, wherein said at least one segment of fungal DNA amplified in step c) comprises a segment of a fungal gene for 18ssu-rRNA.
- 27. A method for detection of fungal DNA in clinical material comprising:a) isolating predominantly intact fungal cells from whole blood by disintegrating blood cells by osmotic hemolysis and enzymatic digestion, and isolating intact fungal cells; b) isolating fungal DNA from the intact fungal cells by disintegrating the intact fungal cells by alkaline lysis and enzymatic treatment and isolating the fungal DNA; c) amplifying at least one segment of the fungal DNA to be detected by polymerase chain reaction using at least one primer; d) determining whether the nucleotide sequence of said at least one segment of fungal DNA is characteristic of a particular fungal strain and/or species, wherein said at least one segment of fungal DNA is hybridized with DNA probes specific for the particular fungal strain and/or species, and wherein a successful hybridization leads to identification of the fungal strain and/or species.
- 28. The method of claim 27, wherein the at least one primer in step c) is selected from the group consisting of SEQ ID-No: 1 and SEQ ID-No: 2.
- 29. The method of claim 27, wherein the DNA probes in step d) are selected from the group consisting of SEQ ID-No: 3, SEQ ID-No: 4, SEQ ID-No: 5, SEQ ID-No: 6, SEQ ID-No: 7 and SEQ ID-No: 8.
- 30. A method for detection of fungal DNA in clinical material comprising:a) isolating predominantly intact fungal cells from whole blood by disintegrating blood cells and isolating intact fungal cells; b) isolating fungal DNA from the intact fungal cells by disintegrating the intact fungal cells and isolating the fungal DNA; c) amplifying at least one segment of the fungal DNA to be detected by polymerase chain reaction using at least one primer; and d) determining whether the nucleotide sequence of said at least one segment of fungal DNA is characteristic of a particular fungal strain and/or species, wherein said at least one segment of fungal DNA is hybridized with DNA probes specific for the particular fungal strain and/or species, and wherein a successful hybridization leads to identification of the fungal strain and/or species.
- 31. The method of claim 30, wherein the at least one primer in step c) is selected from the group consisting of SEQ ID-No: 1 and SEQ ID-No: 2.
- 32. The method of claim 30, wherein the DNA probes in step d) are selected from the group consisting of SEQ ID-No: 3, SEQ ID-No: 4, SEQ ID-No: 5, SEQ ID-No: 6, SEQ ID-No: 7 and SEQ ID-No: 8.
Priority Claims (3)
Number |
Date |
Country |
Kind |
195 30 333 |
Aug 1995 |
DE |
|
195 30 336 |
Aug 1995 |
DE |
|
195 30 332 |
Aug 1995 |
DE |
|
Parent Case Info
This application is a continuation of U.S. patent application Ser. No. 09/011,931. filed on Jun. 22, 1998, now abandoned, which was the U.S. National Phase under 35 U.S.C. §371 of International Application No. PCT/EP96/03580, filed Aug. 13, 1996 and published in German, which claims priority to German Application Nos. 195 30 332.6, filed Aug. 17, 1995, 195 30 333.4, filed Aug. 17, 1995 and German Application No. 195 30 336.9, filed Aug. 17, 1995.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
4130395 |
Chryssanthou |
Dec 1978 |
A |
5426026 |
Jordan et al. |
Jun 1995 |
A |
5426027 |
Lott et al. |
Jun 1995 |
A |
5434048 |
Simon et al. |
Jul 1995 |
A |
Foreign Referenced Citations (7)
Number |
Date |
Country |
0 285 439 |
Oct 1988 |
EP |
0 335 633 |
Oct 1989 |
EP |
0 422 869 |
Apr 1991 |
EP |
0 574 267 |
Dec 1993 |
EP |
08 089 254 |
Apr 1996 |
JP |
WO9208807 |
May 1992 |
WO |
WO9323568 |
Nov 1993 |
WO |
Non-Patent Literature Citations (3)
Entry |
Journal of Clinical Microbiology Bd. 32, Nr. 1, Jan. 1994, Holmes et al.: Detection of Candida albicans and Other Yeasts in Blood by PCR. |
Bone Marrow Transplantation, 13 Marz 1994, Seite 184 XP000645489; Einsele H. et al: “Detection of Various Fungal Pathogens in Blood Samples by PCR”. |
Surgery, Aug. 1990, Buchman, et al., Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene, vol. 108, No. 2, pp. 338-347. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09/011931 |
Jun 1998 |
US |
Child |
09/867372 |
|
US |